AGF US Market Neutral Anti-Beta Fund
BTAL
5 hedge funds and large institutions have $4.6M invested in AGF US Market Neutral Anti-Beta Fund in 2014 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 0 closing their positions.
1,270% more capital invested
Capital invested by funds: $336K → $4.6M (+$4.27M)
148.08% more ownership
Funds ownership: 11.68% → 159.77% (+148%)
25% more funds holding
Funds holding: 4 → 5 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
ICC Capital Management
Orlando,
Florida
|
+$4.02M |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$284K |
| 3 |
U
UBS
Zurich,
Switzerland
|
+$18.9K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ICM
1
ICC Capital Management
Orlando,
Florida
| $3.97M | +$4.02M | +206,570 | New |
|
|
VKH
2
Virtu KCG Holdings
New York
| $544K | +$284K | +14,584 | +106% |
|
3
Citigroup
New York
| $66K | – | – | – |
|
|
U
4
UBS
Zurich,
Switzerland
| $21K | +$18.9K | +973 | +973% |
|
|
CG
5
Colony Group
Boston,
Massachusetts
| $5K | – | – | – |
|
BTAL Hedge Fund Activity: Q2 2014 in Review
5 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in AGF US Market Neutral Anti-Beta Fund (BTAL) for Q2 2014, worth a combined $4.6M — up 1,270% from $336K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new BTAL positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 0 trimmed.
The largest buyer was ICC Capital Management, opening a new position worth an estimated $4.02M.
- 5 institutional investors held AGF US Market Neutral Anti-Beta Fund (BTAL) as of Q2 2014, up from 4 in Q1 2014.
- Funds reported $4.6M of AGF US Market Neutral Anti-Beta Fund stock for Q2 2014, up 1,270% quarter-over-quarter.
- 1 fund opened new AGF US Market Neutral Anti-Beta Fund positions in Q2 2014 and 0 closed out, a net change of +1 holder.
- The largest AGF US Market Neutral Anti-Beta Fund buyer in Q2 2014 was ICC Capital Management, an estimated $4.02M added.
Based on aggregated 13F filings for Q2 2014.